Harvard-MIT CRS responds to the COVID-19 Pandemic
Fellows, faculty and staff in the Harvard-MIT Center for Regulatory Science (CRS) and its sister program, The Laboratory of Systems Pharmacology, are engaged in multiple new research and community projects in response to the COVID-19 pandemic. See publications here.
To address rapidly emerging shortages in medical supplies and devices, the Harvard-MIT CRS is coordinating Greater Boston Pandemic Fabrication Team (PanFab). PanFab has mobilized a team of regulatory science fellows, volunteer scientists, engineers, clinicians, and concerned citizens. The PanFab team is helping healthcare professionals, first responders and patients by using innovative approaches to alleviate shortages in medical products, coordinate product testing and promote hospital uptake of new solutions. PanFab is also studying the problems in healthcare made apparent by COVID19 from a rigorous scientific and engineering perspective and it is documenting its findings in pre-prints and peer-reviewed publications. Contact email@example.com for more information.
Members of the Laboratory of Systems Pharmacology (LSP) are working on rapid diagnostic tests that require a minimum of specialized equipment to perform. They are also investigating new and existing therapeutics to identify those with the potential to reduce COVID19 symptoms. Finally, the LSP is using its highly multiplexed imaging platform to investigate mechanisms of SARS-CoV-2 pathogenesis and better understand why some patients are severely affected and others are not.